Jane Street’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
Other funds holding HELX
HI
HHGA
Jane Street's HELX Position: Q2 2025 in Review
Jane Street sold out of Franklin Genomic Advancements ETF (HELX) in Q2 2025, closing a stake of 8,049 shares — an estimated $217K sold.
Jane Street first reported a position in HELX in Q3 2020 and held it in 16 quarters. The position peaked at $5.54M in Q4 2021. 8 funds tracked by Wall St. Rank hold HELX as of Q2 2025.
- Jane Street reported no remaining Franklin Genomic Advancements ETF position as of Q2 2025 after selling out during the quarter.
- Jane Street sold 8,049 Franklin Genomic Advancements ETF shares in Q2 2025, an estimated $217K.
- Jane Street first reported a position in Franklin Genomic Advancements ETF in Q3 2020 and held it in 16 quarters.
- Jane Street's Franklin Genomic Advancements ETF position peaked at $5.54M in Q4 2021.
- 8 funds tracked by Wall St. Rank held Franklin Genomic Advancements ETF as of Q2 2025.
Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.